Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLAPARIB vs OLECLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLAPARIB vs OLECLUMAB: Safety Overview

Metric OLAPARIB OLECLUMAB
Total FAERS Reports 18,274 118
Deaths Reported 5,496 14
Death Rate 30.1% 11.9%
Hospitalizations 3,471 102
Average Patient Age 62.3 yrs 63.4 yrs
% Female Patients 79.9% 41.7%
FDA Approval Date Aug 17, 2017 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Discontinued N/A